Trial Profile
Postpartum HPV Vaccination: Acceptability, Uptake and Immunogenicity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2022
Price :
$35
*
At a glance
- Drugs V 503 (Primary)
- Indications Human papillomavirus infections
- Focus Therapeutic Use
- 08 Sep 2021 Status changed from active, no longer recruiting to completed.
- 29 Jul 2020 Status changed from recruiting to active, no longer recruiting.
- 25 Mar 2020 Planned End Date changed from 30 Jun 2020 to 30 Dec 2020.